Androgen receptor drives polyamine synthesis creating a vulnerability for prostate cancer

Insights

Supraphysiological androgens (SPA) boost polyamine synthesis in prostate cancer by activating the androgen receptor (AR) to regulate ODC1. Inhibiting polyamine synthesis enhances SPA efficacy, revealing a therapeutic vulnerability.

Area of Science:

  • Oncology
  • Molecular Biology
  • Metabolic Pathways

Background:

  • Supraphysiological androgen (SPA) treatment, including Bipolar Androgen Therapy (BAT), paradoxically inhibits castration-resistant prostate cancer (CRPC) growth in AR-active tumors.
  • The metabolic alterations induced by SPA and their impact on CRPC progression and therapeutic response remain poorly understood.

Purpose of the Study:

  • To investigate the metabolic changes, specifically polyamine synthesis, induced by SPA in prostate cancer models.
  • To elucidate the mechanism by which SPA influences polyamine metabolism and its role in CRPC progression.
  • To evaluate the therapeutic potential of targeting polyamine synthesis in combination with SPA.

Main Methods:

  • Utilized prostate cancer models to assess the impact of SPA on intracellular and secreted polyamines.
  • Investigated the role of androgen receptor (AR) binding to enhancer sites upstream of the Ornithine Decarboxylase 1 (ODC1) promoter.
  • Employed dCas9-KRAB-mediated inhibition of AR regulation and difluoromethylornithine (DFMO) to inhibit ODC activity.
  • Assessed the effects of polyamine depletion on S-adenosylmethionine decarboxylase 1 (AMD1) activity and global protein methylation.
  • Conducted a Phase I clinical trial combining BAT and DFMO in metastatic CRPC patients, including pharmacodynamic studies.

Main Results:

  • SPA significantly increased intracellular and secreted polyamines in prostate cancer models.
  • AR binding at enhancer sites increased ODC1 abundance, driving de novo polyamine synthesis from arginine.
  • Inhibition of AR-driven ODC1 or ODC activity with DFMO enhanced the efficacy of SPA treatment.
  • SPA increased AMD1 activity, partly due to AR stimulation and reduced polyamine feedback, leading to S-adenosylmethionine depletion and decreased global protein methylation.
  • Pharmacodynamic studies in patients showed effective plasma polyamine depletion with the BAT + DFMO combination.

Conclusions:

  • Androgen receptor (AR) potently stimulates polyamine synthesis in prostate cancer.
  • SPA-induced polyamine synthesis represents a critical metabolic vulnerability in AR-driven prostate cancer.
  • Targeting polyamine synthesis, for example with DFMO, in combination with SPA (BAT) offers a promising therapeutic strategy for metastatic CRPC.

Related Concept Videos

Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
69.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
2
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K